Finally, an endocytosis blocker able to target dynamin-2 reduced the absorption of exosomes by MM plasma cells ex vivo and increased the anti-MM actions of Bz in vitro and in an experimental animal model [123]. Here, DNM2 is linked to Miyoshi myopathy.